Hamilton Beach Brands Holding Company

Second-quarter revenue was $142.6 million, up 11.6% from $127.8 million a year ago. Gross profit was $77.5 million versus $35.1 million, and gross margin was 54.3% versus 27.5%; excluding tariff-refund benefits, Q2 gross margin was 26.1%. Operating profit rose to $43.2 million from $5.9 million, and net income was $33.7 million, or $2.49 per diluted share, versus $4.5 million, or $0.33 per diluted share last year. The company said 2026 revenue growth is still expected to approach the mid-single-digit range, gross margins are now expected to improve modestly over 2025, and operating profit is expected to be down high single digits; operating cash flow for 2026 is still expected to be in the range of $35 million to $45 million.

Scott Tidey said the quarter showed “meaningful improvement” in underlying operating performance, driven by stronger U.S. consumer volumes and better gross margin despite a difficult tariff backdrop. He highlighted progress across all five growth pillars, including new product launches, premium brand expansion, commercial wins, AI-driven digital transformation, and continued profitable growth in Hamilton Beach Health. His tone was constructive and forward-looking, emphasizing that the business has momentum and remains positioned to drive top-line growth in the back half of the year and beyond.

Sally Cunningham emphasized that the quarter benefited from the $36.5 million IEPA tariff refund, but also noted that underlying gross margin improved, with Q2 ex-refund gross margin at 26.1% and better than expected. She detailed higher SG&A of $34.3 million, driven by incentive expense and $1.4 million of accelerated depreciation on the legacy ERP system, and said operating profit increased to $43.2 million. On the balance sheet, operating cash flow for the first six months was $61.5 million, inventory fell to $115.1 million from $160.4 million, the company repurchased about 98,000 shares for $2 million, paid $1.7 million in dividends, and ended Q2 with a net cash position of $51.5 million.

The main analyst question focused on why share repurchases appeared slower despite the company’s strong cash generation and large cash balance. Sally Cunningham said capital allocation philosophy has not changed and buybacks depend on outlook, planned uses of cash, strategic priorities, and available float, while Scott Tidey added that the company sees multiple investment opportunities tied to its strategic initiatives and will invest appropriately. Management framed capital allocation as a balance between shareholder returns and reinvestment for growth, rather than a shift away from repurchases.